Danaher (NYSE: DHR) announced two key leadership appointments to advance its digital transformation and Life Sciences division.
Martin Stumpe will become chief technology and AI officer, effective October 1, 2025. Stumpe, who joined last year as chief data and AI officer, reports directly to CEO Rainer Blair. He brings experience from Tempus, Google’s Cancer Pathology project, and NASA’s Kepler team.
Greg Milosevich is named executive vice president overseeing Life Sciences, effective July 1, 2025. Milosevich has led Danaher’s Life Sciences Innovations Group since 2021 and has held increasing responsibilities since joining via Molecular Devices in 2010.
“These appointments mark a pivotal step in accelerating Danaher’s integration of AI and driving Life Sciences growth,” said Blair.
Follow MEDWIRE.AI for leadership and innovation updates in MedTech.
